ABUS

ABUS Earnings Preview

Arbutus Biopharma Corporation · Healthcare · $829M

14d until earnings

ABUS Earnings

Wednesday, May 13 2026
EPS Estimate
$-0.06
$-0.06 – $-0.06
Revenue Estimate
$2M
Current Price
$4.28

Data Signal Summary

1 bullish
2 bearish
Insider selling cluster Put/call 0.6 (bullish skew) Price downtrend

Key Context

Insider Activity
selling
Price Trend
downtrend
From 52w High
-9.3%
Est. Revisions (30d)
+1.8% 0up/1dn
Analyst Target (mean)
$5 $5–$6 +22%
Options P/C Ratio
0.55
Est. Dispersion
0% 1 analysts
Insider Cluster
strong sell
Fund Convergence
moderate D.E. Shaw, Citadel

Recent Activity

insider trades 12 transactions
Award · ANDROSKI LINDSAY J.D. (Chief Executive Officer) ·28,000 shares
Award · NGUYEN TUAN (Chief Financial Officer) ·73,500 shares
Award · NAFTZGER J CHRISTOPHER (General Counsel) ·54,300 shares
Award · HASTINGS DAVID C (Chief Financial Officer) ·90,100 shares
Award · SIMS KAREN (Officer) ·49,300 shares
7 more
Sell · NAFTZGER J CHRISTOPHER ·11,333 shr ·$37,206
Sell · HASTINGS DAVID C ·22,183 shr ·$72,827
Sell · SIMS KAREN ·19,348 shr ·$63,519
Sell · MANCHESTER KEITH S ·8,846 shr ·$32,637
Exercise · MANCHESTER KEITH S ·54,915 shr ·$30,752
Other · Androski (Lindsay J.D.) ·28,000 shr
Other · Nguyen (Tuan) ·73,500 shr